From: Optimal drug regimens for improving ALP biochemical levels in patients with primary biliary cholangitis refractory to UDCA: a systematic review and Bayesian network meta-analysis
Comparison
p value
bezafibrate + UDCA/fenofibrate + UDCA
0.08
bezafibrate + UDCA/UDCA
0.07
fenofibrate + UDCA/UDCA